Abstract
The contribution of protein fraction and proteolytic enzyme preparation to the in vitro cardioprotective, anti-diabetic and antioxidant activity of Palmaria palmata protein hydrolysates was investigated. Aqueous, alkaline and combined aqueous and alkaline P. palmata protein fractions were hydrolysed with the food-grade proteolytic preparations, Alcalase 2.4 L, Flavourzyme 500 L and Corolase PP. The hydrolysates had angiotensin converting enzyme (ACE) and dipeptidyl peptidase (DPP) IV inhibitory activity with IC50 values in the range 0.19–0.78 and 1.65–4.60 mg mL−1, respectively. The oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant power (FRAP) values ranged from 45.17 to 467.54 and from 1.06 to 21.59 μmol trolox equivalents/g, respectively. Furthermore, hydrolysates (1 mg mL−1) were show to inhibit renin within the range 0–50 %. In general, Alcalase 2.4 L and Corolase PP hydrolysates of aqueous protein displayed the highest in vitro activity. The results indicate that protein fraction and enzyme preparation used have significant effects on in vitro biofunctional activity of the hydrolysates. This study demonstrates the potential of P. palmata protein hydrolysates as multifunctional functional food ingredients for the prevention/control of hypertension and type II diabetes.
Similar content being viewed by others
References
Boots JWP (2006) Protein hydrolysates enriched in peptides inhibiting DPP-IV and their use. PCT Patent Application WO/2006/068480
Cha SH, Ahn GN, Heo SJ, Kim KN, Lee KW, Song CB, Cho SK, Jeon YJ (2006) Screening of extracts from marine green and brown algae in Jeju for potential marine angiotensin-I converting enzyme (ACE) inhibitory activity. J Korean Soc Food Sci Nutr 35:307–314
Cian RE, Alaiz M, Vioque J, Drago SR (2012) Enzyme proteolysis enhanced extraction of ACE inhibitory and antioxidant compounds (peptides and polyphenols) from Porphyra columbina residual cake. J Appl Phycol. doi:10.1007/s10811-012-9913-2
Fatehi-Hassanabad Z, Chan CB, Furman BL (2010) Reactive oxygen species and endothelial function in diabetes. Eur J Pharmacol 636:8–17
Fitzgerald C, Mora-Soler L, Gallagher E, O’Connor P, Prieto J, Soler-Vila A, Hayes M (2012) Isolation and characterization of bioactive pro-peptides with in vitro renin inhibitory activities from the macroalga Palmaria palmata. J Agric Food Chem 60:7421–7427
Fleurence J (2004) Seaweed proteins. In: Yada RY (ed) Proteins in food processing. Woodhead Publishing Limited, Cambridge, pp 197–213
Girgih AT, Udenigwe CC, Li H, Adebiyi AP, Aluko RE (2011) Kinetics of enzyme inhibition and antihypertensive effects of hemp seed (Cannabis sativa L.) protein hydrolysates. JAOCS 88:1767–1774
Green BD, Gault VA, O’Harte FP, Flatt PF (2004) Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents. Curr Pharm Des 10:3651–3662
Harnedy PA, FitzGerald RJ (2011) Bioactive proteins, peptides and amino acids from macroalgae. J Phycol 47:218–232
Harnedy PA, FitzGerald RJ (2013) Extraction of protein from the macroalga Palmaria palmata. LET Food Sci Technol 51:375–382
He HL, Chen XL, Wu H, Sun CY, Zhang YZ, Zhou BC (2007) High throughput and rapid screening of marine protein hydrolysates enriched in peptides with angiotensin-I-converting enzyme inhibitory activity by capillary electrophoresis. Bioresour Technol 98:3499–3505
Kalyankar P, Zhu Y, O’Keeffe M, O’Cuinn G, FitzGerald RJ (2013) Substrate specificity of glutamyl endopeptidase (GE): hydrolysis studies with a bovine α-casein preparation. Food Chem 136:501–512
Kelman D, Posner EK, McDermid KJ, Tabandera NK, Wright PR, Wright AD (2012) Antioxidant activity of Hawaiian marine algae. Mar Drugs 10:403–416
Kurtz TW, Pravenec M (2004) Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin–angiotensin system. J Hypertens 22:2253–2261
Lacroix IME, Li-Chan ECY (2012a) Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. Int Dairy J 25:97–102
Lacroix IME, Li-Chan ECY (2012b) Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach. J Funct Foods 4:403–422
Lago RM, Singh PP, Nesto RW (2007) Diabetes and hypertension. Nat Clin Pract Endocrinol Metab 3:667–667
Lee JM, You SG, Kim SM (2005) Functional activities of low molecular weight peptides purified from enzymatic hydrolysates of seaweeds. J Korean Soc Food Sci Nutr 34:1124–1129
Li H, Aluko RE (2010) Identification and inhibitory properties of multifunctional peptides from pea protein hydrolysate. J Agric Food Chem 58:11471–11476
Li H, Prairie N, Udenigwe CC, Adebiyi AP, Tappia PS, Aukema HM, Jones PJ, Aluko RE (2011) Blood pressure lowering effect of a pea protein hydrolysate in hypertensive rats and humans. J Agric Food Chem 59:9854–9860
Li-Chan EC, Hunag SL, Jao CL, Ho KP, Hsu KC (2012) Peptides derived from atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors. J Agric Food Chem 60:973–978
Meisel H, Walsh DJ, Murray BA, FitzGerald RJ (2006) ACE inhibibtory peptides. In: Mine Y, Shahidi F (eds) Nutraceutical proteins and peptides in health and disease, vol 4. CRC Press, Boca Raton, pp 269–315
Mullally MM, O’Callaghan DM, FitzGerald RJ, Donnelly WJ, Dalton JP (1994) Proteolytic and peptidolytic activities in commercial pancreatic protease preparations and their relationship to some whey protein hydrolyzate characteristics. J Agric Food Chem 42:2973–2981
Murray BA, Walsh DJ, FitzGerald RJ (2004) Modification of the furanacryloyl-l-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity. J Biochem Biophys Methods 59:127–137
Nongonierma AB, FitzGerald RJ (2013) Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates. Peptides 39:157–163
Norris R, Casey F, FitzGerald RJ, Shields D, Mooney C (2012) Predictive modelling of angiotensin converting enzyme inhibitory dipeptides. Food Chem 133:1349–1354
Papaharalambus CA, Griendling KK (2007) Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 17:48–54
Saito M, Hagino H (2005) Antihypertensive effect of oligopeptides derived from nori (Porphyra yezoensis) and Ala-Lys-Tyr-Ser-Tyr in rats. J Jap Soc Nutr Food Sci 58:177–184
Sato M, Hosokawa T, Yamaguchi T, Nakano T, Muramoto K, Kahara T, Funayamab K, Kobayashib A, Nakano T (2002a) Angiotensin I-converting enzyme inhibitory peptides derived from brown alga (Undaria pinnatifida) and their antihypertensive effect in spontaneously hypertensive rats. J Agric Food Chem 50:6245–6252
Sato M, Oba T, Yamaguchi T, Nakano T, Kahara T, Funayama K, Kobayashi A, Nakano T (2002b) Antihypertensive effects of hydrolysates of Wakame (Undaria pinnatifida) and their angiotensin I-converting enzyme inhibitory activity. Ann Nutr Metab 46:259–267
Sentandreu MÁ, Toldrá F (2006) A rapid, simple and sensitive fluorescence method for the assay of angiotensin-I converting enzyme. Food Chem 97:546–554
Smyth M, FitzGerald RJ (1998) Relationship between some characteristics of WPC hydrolysates and the enzyme complement in commercially available proteinase preparations. Int Dairy J 8:819–827
Sowers JR (2004) Treatment of hypertension in patients with diabetes. Arch Intern Med 164:1850–1857
Spellman D, McEvoy E, O’Cuinn G, FitzGerald RJ (2003) Proteinase and exopeptidase hydrolysis of whey protein: comparison of the TNBS, OPA and pH stat methods for quantification of degree of hydrolysis. Int Dairy J 13:447–453
Spellman D, Kenny P, O’Cuinn G, FitzGerald RJ (2005) Aggregation properties of whey protein hydrolysates generated with Bacillus licheniformis proteinase activities. J Agric Food Chem 53:1258–1265
Suetsuna K (1998a) Purification and identification of angiotensin I-converting enzyme inhibitors from the red alga Porphyra yezoensis. J Mar Biotechnol 6:163–167
Suetsuna K (1998b) Separation and identification of angiotensin I-converting enzyme inhibitory peptides from peptic digest of Hizikia fusiformis protein. Nippon Suisan Gakk 64:862–866
Suetsuna K, Nakano T (2000) Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida). J Nutr Biochem 11:450–454
Tulipano G, Sibilia V, Caroli AM, Cocchi D (2011) Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors. Peptides 32:835–838
Uchida M, Ohshiba Y, Mogam O (2011) Novel dipeptidyl peptidase-4-inhibiting peptide derived from β-lactoglobulin. J Pharmacol Sci 117:63–66
Udenigwe CC, Lin Y-S, Hou W-C, Aluko RE (2009) Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions. J Funct Foods 1:199–207
Uenishi H, Kabuki T, Seto Y, Serizawa A, Nakajima H (2012) Isolation and identification of casein-derived dipeptidyl-peptidase 4 (DPP-4)-inhibitory peptide LPQNIPPL from gouda-type cheese and its effect on plasma glucose in rats. Int Dairy J 22:24–30
Van Amerongen A, Beelen-Thomissen MJC, Van Zeeland-Wolbers LAM, Van Gilst WH, Buikema JH, Nelissen JWPM (2009) Egg protein hydrolysates. PCT Patent Application WO/2009/128713
Wang T, Jónsdóttir R, Kristinsson HG, Hreggvidsson GO, Jónsson JO, Thorkelsson G, Ólafsdóttir G (2010) Enzyme-enhanced extraction of antioxidant ingredients from red algae Palmaria palmata. LWT - Food Sci Technol 43:1387–1393
Wijesekara I, Kim SK (2010) Angiotensin-I-converting enzyme (ACE) Inhibitors from marine resources: Prospects in the pharmaceutical industry. Mar Drugs 8:1080–1093
Acknowledgments
This project (Grant Aid Agreement No. MFFRI/07/01) was carried out under the Sea Change Strategy with the support of the Marine Institute and the Department of Agriculture, Food and the Marine, funded under the National Development Plan 2007–2013. The authors would like to acknowledge Dr. Anna Soler-Vila, NUI Galway for the freeze-dried P. palmata sample.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harnedy, P.A., FitzGerald, R.J. In vitro assessment of the cardioprotective, anti-diabetic and antioxidant potential of Palmaria palmata protein hydrolysates. J Appl Phycol 25, 1793–1803 (2013). https://doi.org/10.1007/s10811-013-0017-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10811-013-0017-4